Skip to Main Content

Paper Details

A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer.
Epigenomics
3
2022
Author NameAffiliation
Martin Hirst
Martin HirstUniversity of British Columbia
Wei XuPrincess Margaret Cancer Centre, University Health Network
Bharati BapatLunenfeld-Tanenbaum Research Institute
Bharati BapatUniversity of Toronto
  • 1 - 5

Datasets

Release 1.2